Immunotherapy Making Strides at ASCO-SITC Immuno-Oncology Symposium

In late February, the American Society of Clinical Oncology (ASCO) partnered with the Society for Immunotherapy of Cancer (SITC) to host the first ASCO-SITC Clinical Immuno-Oncology Symposium, held in Orlando. We learned, along with 1000 other attendees, about the...

Response to FiercePharma Article

CLIENT: Pierian Biosciences DATE: February 17, 2017 PROJECT: PR – Blog post – Response to FiercePharma article Author: Robert Henry A recent FiercePharma article on the top 15 cancer drugs for 2022 predicts they will total nearly $90 billion in sales. That’s a...

PR – Op-Ed: Response to New Clinical Trials Requirements from HHS

Client: DiaTech Holdings/Pierian Biosciences, Inc. Date: September 21, 2016 Project: PR – Op-Ed: Response to New Clinical Trials Requirements from HHS Cancer deaths have declined substantially in the past decade. According to the National Cancer Institute, from 2003...
The Promise of Precision Medicine

The Promise of Precision Medicine

Cancer. The numbers tell the story. 1.6 + million people diagnosed this year. National expenditures for cancer care totaling nearly $125 billion. Significant advances in the last thirty years of creating standards of care for many diseases. Effectively treating cancer...